Afya Limited reports financial, regulatory and capital-allocation developments for a Brazil-based medical education group and medical practice solutions provider. The company serves medical students and physicians through an end-to-end ecosystem that includes undergraduate medical education, residency preparation, continuing medical education, graduate programs and practice-management solutions.
Recurring company developments include IFRS financial results in Brazilian reais, medical-seat authorizations from Brazil’s Ministry of Education, campus-level capacity changes, credit-rating actions, dividends, share repurchases and board changes. Afya also reports activity in continuing education, B2B revenue, clinical management tools and the broader physician base that uses its education and medical practice platforms.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Afya Limited (NASDAQ: AFYA) has initiated a new share repurchase program after completing its previous one, which bought back 1,874,457 Class A shares. The new program allows for the repurchase of up to 2,000,000 shares, representing about 5.8% of its free float, approved by the Board on March 23, 2023. These repurchases will be conducted through a trading plan with BofA Securities, adhering to SEC regulations. The shares are intended for use in stock option programs, future business combinations, and corporate purposes. Purchases will depend on market conditions and are expected to enhance shareholder value.
Afya Limited (Nasdaq: AFYA) reported robust financial results for Q4 and FY 2022, achieving a 32.3% year-over-year increase in adjusted net revenue to R$2.32 billion. Q4 adjusted net revenue rose 17.8% to R$595.1 million, with adjusted EBITDA up 24.1% to R$242.2 million, resulting in a margin of 40.7%. Adjusted net income for Q4 surged 30.8% to R$128.8 million, reflecting a 53.3% EPS growth. The company also announced a guidance range for 2023 of R$2.75 billion to R$2.85 billion in adjusted revenue.
Afya Limited has completed the acquisition of 100% of Sociedade Educacional e Cultural Sergipe DelRey Ltda. for an enterprise value of R$825 million. The acquisition enhances Afya's portfolio by adding 340 medical school seats, increasing its total to 3,163, with projected annual revenue of R$261 million by 2024. A contingent payment could add R$1.25 million per seat if the Ministry of Education approves additional medical seats by December 2024. This marks Afya's largest acquisition to date, expanding its presence into the Alagoas state and reinforcing its leadership in Brazilian medical education.
Afya Limited (NASDAQ: AFYA) announced the authorization of an increase of 64 medical seats at Faculdade Santo Agostinho in Itabuna, Bahia, now totaling 149 seats. This boosts Afya's overall approved medical seats to 2,823, potentially serving around 20,326 students at maturity, considering financial aid programs. As of September 30, 2022, Afya had 17,997 medical students. This growth highlights Afya's position as a leading medical education provider in Brazil, focused on enhancing educational opportunities for future physicians.